Enhancement of oral bioavailability of fenofibrate by solid self-microemulsifying drug delivery systems

References

• Adkins JC, Faulds D. (1997). Micronised fenofibrate: a review of its pharmacodynamic properties and clinical efficacy in the management of dyslipidaemia. Drugs, 54:615–633.
   PubMed Web of Science ®Google Scholar
• Balfour JA, McTavish D, Heel RC. (1990). Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs, 40:260–290.
   PubMed Web of Science ®Google Scholar
• Genest J Jr, Nguyen NH, Theroux P, Davignon J, Cohn JS. (2000). Effect of micronized fenofibrate on plasma lipoprotein levels and hemostatic parameters of hypertriglyceridemic patients with low levels of high-density lipoprotein cholesterol in the fed and fasted state. J Cardiovasc Pharmacol, 35:164–172.
   PubMed Web of Science ®Google Scholar
• Packard CJ. (1998). Overview of fenofibrate. Eur Heart J, 19 Suppl A:A62–A65.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413–420.
   PubMed Web of Science ®Google Scholar
• Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS et al. (2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm, 1:85–96.
   PubMed Web of Science ®Google Scholar
• Patel AR, Vavia PR. (2006). Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macro, 56:247–251.
   Web of Science ®Google Scholar
• Law D, Wang W, Schmitt EA, Qiu Y, Krill SL, Fort JJ. (2003). Properties of rapidly dissolving eutectic mixtures of poly(ethylene glycol) and fenofibrate: the eutectic microstructure. J Pharm Sci, 92:505–515.
   PubMed Web of Science ®Google Scholar
• Curtet B, Teillaud E, Reginault P. inventors. (1980.) Fournier Innovation et Synergie, assignee. Novel dosage form of fenofibrate. US patent 4: 895 726.
   Google Scholar
• Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci, 29:278–287.
   PubMed Web of Science ®Google Scholar
• Rane SS, Anderson BD. (2008). What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev, 60:638–656.
   PubMed Web of Science ®Google Scholar
• Cui SX, Nie SF, Li L, Wang CG, Pan WS, Sun JP. (2009). Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine. Drug Dev Ind Pharm, 35:603–611.
   PubMed Web of Science ®Google Scholar
• Woo JS, Song YK, Hong JY, Lim SJ, Kim CK. (2008). Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci, 33:159–165.
   PubMed Web of Science ®Google Scholar
• Chang RK, Raghavan KS, Hussain MA. (1998). A study on gelatin capsule brittleness: moisture tranfer between the capsule shell and its content. J Pharm Sci, 87:556–558.
   PubMed Web of Science ®Google Scholar
• Nazzal S, Wang Y. (2001). Characterization of soft gelatin capsules by thermal analysis. Int J Pharm, 230:35–45.
   PubMed Web of Science ®Google Scholar
• Mei X, Etzler FM, Wang Z. (2006). Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules. Int J Pharm, 324:128–135.
   PubMed Web of Science ®Google Scholar
• Franceschinis E, Voinovich D, Grassi M, Perissutti B, Filipovic-Grcic J, Martinac A et al. (2005). Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption. Int J Pharm, 291:87–97.
   PubMed Web of Science ®Google Scholar
• Choi HG, Lee BJ, Han JH, Lee MK, Park KM, Yong CS et al. (2001). Terfenadine-beta-Cyclodextrin inclusion complex with antihistaminic activity enhancement. Drug Dev Ind Pharm, 27:857–862.
   PubMed Web of Science ®Google Scholar
• Li DX, Oh YK, Lim SJ, Kim JO, Yang HJ, Sung JH et al. (2008). Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique. Int J Pharm, 355:277–284.
   PubMed Web of Science ®Google Scholar
• Society of Toxicology (SOT). (1999). Guiding principles in the use of animals in toxicology. Available from: http://www.toxicology.org/ai/fa/guidingprinciples.pdf ( Accessed 21 August 2011).
   Google Scholar
• Hanafy A, Spahn-Langguth H, Vergnault G, Grenier P, Tubic Grozdanis M, Lenhardt T et al. (2007). Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliv Rev, 59:419–426.
   PubMed Web of Science ®Google Scholar
• Pradhan R, Lee DW, Choi HG, Yong CS, Kim JO. (2012). Fabrication of a uniformly sized fenofibrate microemulsion by membrane emulsification. J Microencapsul, doi:10.3109/02652048.2012.692403
   PubMed Web of Science ®Google Scholar
• Cole ET, Cadé D, Benameur H. (2008). Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration. Adv Drug Deliv Rev, 60:747–756.
   PubMed Web of Science ®Google Scholar
• Prasad YV, Puthli SP, Eaimtrakarn S, Ishida M, Yoshikawa Y, Shibata N et al. (2003). Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. Int J Pharm, 250:181–190.
   PubMed Web of Science ®Google Scholar
• Kang BK, Lee JS, Chon SK, Jeong SY, Yuk SH, Khang G et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm, 274:65–73.
   PubMed Web of Science ®Google Scholar
• Pouton C. (1985). Effects of the inclusion of a model drug on the performance of self-emulsifying formulations. J Pharm Pharmacol, 37:1P–4P.
   Web of Science ®Google Scholar
• Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45:89–121.
   PubMed Web of Science ®Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP et al. (2009). Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm, 72:539–545.
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. (2005). Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int J Pharm, 293:155–164.
   PubMed Web of Science ®Google Scholar
• Yan YD, Kim JA, Kwak MK, Yoo BK, Yong CS, Choi HG. (2011). Enhanced oral bioavailability of curcumin via a solid lipid-based self-emulsifying drug delivery system using a spray-drying technique. Biol Pharm Bull, 34:1179–1186.
   PubMed Web of Science ®Google Scholar
• Oh DH, Kang JH, Kim DW, Lee BJ, Kim JO, Yong CS et al. (2011). Comparison of solid self-microemulsifying drug delivery system (solid SMEDDS) prepared with hydrophilic and hydrophobic solid carrier. Int J Pharm, 420:412–418.
   PubMed Web of Science ®Google Scholar